Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Link opens in a new tab
English
Español
Search content at University of Kentucky
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
FGF-23 and sclerostin in serum and bone of CKD patients
Florence Lima
, Marie Claude Monier-Faugere
, Hanna Mawad
, Valentin David
, Hartmut H. Malluche
Internal Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
23
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'FGF-23 and sclerostin in serum and bone of CKD patients'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Chronic Kidney Disease
100%
Sclerostin
100%
Fibroblast Growth Factor 23
100%
Kidney Function
23%
Bone Turnover
23%
Cancellous Bone
15%
Cortical Bone
15%
Protein Expression
7%
Tetracycline
7%
Renal Osteodystrophy
7%
Morphometrics
7%
Bone Mass
7%
Osteoblast
7%
Ossification
7%
Osteocyte
7%
Hemodialysis
7%
Bone Histomorphometry
7%
Bone Marrow Biopsy
7%
Bone Mineralization
7%
Osteoid
7%
Immunohistochemistry
7%
Osteoclast
7%
Treatment Modality
7%
Biochemistry, Genetics and Molecular Biology
Sclerostin
100%
Fibroblast Growth Factor 23
100%
Kidney Function
27%
Bone Turnover
27%
Immunostaining
9%
Osteoblast
9%
Ossification
9%
Bone Mass
9%
Protein Expression
9%
Blood Level
9%
Hemodialysis
9%
Osteocyte
9%
Osteoid
9%
Bone Mineralization
9%
Osteoclast
9%
Immunology and Microbiology
Fibroblast Growth Factor 23
100%
Kidney Function
27%
Bone Turnover
27%
Cortical Bone
18%
Osteoclast
9%
Trabecular Bone
9%
Protein Expression
9%
Blood Level
9%
Immunostaining
9%
Ossification
9%
Osteoblast
9%
Osteocyte
9%
Bone Mass
9%
Osteoid
9%
Hemodialysis
9%
Iliac Crest
9%
Bone Mineralization
9%